A Team Of Specialists

P. William Conrad, M.D. PhD. Curriculum Vitae - Go Back

Education and Training:

1992-1996 DePauw University, Greencastle, IN

1996-2000 University of Cincinnati College of Medicine, Cincinnati, OH

Ph.D. in Molecular and Cellular Physiology

2000-2004Case Western Reserve University School of Medicine, Cleveland, OH

M.D. degree

2004-2005Transitional Internship

The Western Pennsylvania Hospital, Pittsburgh, PA

2005-2008 Resident in Ophthalmology

University of Michigan, Kellogg Eye Center, Ann Arbor, MI

2008-2010 Fellow, Vitreoretinal surgery

University of Michigan, Kellogg Eye Center, Ann Arbor, MI



2010-present Clinical Instructor of Ophthalmology, University of Pittsburgh School of Medicine

Membership in Professional Societies:

2010-present Pittsburgh Ophthalmology Society

2010-present American Academy of Ophthalmology

2011-present American Society of Retina Specialists

2011-present Pennsylvania Medical Society



2010 Diplomat, American Board of Ophthalmology

Medical Licensure:

2005-2010 State of Michigan

2010-present State of Pennsylvania


2004 Alpha Omega Alpha Honor Medical Socity

2000 Doane Award as outstanding graduate student in the Department of Molecular and Cellular Physiology, University

of Cincinnati



1.Conrad, P.W., Zacks, D.N and Johnson, M.W. (2008) Intravitreal Bevacizumab has Initial Clinical Benefit Lasting Eight Weeks in Eyes with Neovascular Age-Related Macular Degeneration” Clinical Ophthalmol. 4, 727-33

2.Oefelein, M.G., Ricchiuti, V., Conrad, W. and Resnick, M.I. (2002) “Skeletal fractures negatively correlate with overall survival in men with prostate cancer. Urol. 168, 1005-7

3.Oefelein, M.G., Ricchiuti, V.S., Conrad, P.W., Goldman, H., Bodner, D., Resnick, M.I. and Seftel, A. (2002) Clinical predictors of androgn-independent prostate cancer and survival in the prostate-specific antigen era Urology 60, 120-4

4.Oefelein, M.G., Ricchiuti, V.S., Conrad, P.W., Seftel, A., Bodner, B., Goldman, H. and Resnick, M. (2001) Skeletal fracture associated with androgen suppressioninduced osteoporosis:the clinical incidence and risk factors for patients with prostate cancer J. Urol. 166, 662-3

5.Conrad, P.W., Conforti, L., Kobayashi, S., Beitner-Johnson, D., Rust, R.T., Yuan, Y., Kim, H., Kim, R.H., Seta, K., and Millhorn, D.E. (2001) “The molecular basis of O(2)-sensing and hypoxia tolerance in pheochromocytoma cells Comp Biochem Physiol B Biochem Mol Biol. 128, 187-204

6.Beitner-Johnson, D., Seta, K., Yuan, Y., Kim, H-W., Rust, R.T., Conrad, P.W., Kobayashi, S., and Millhorn, D.E. (2001) Identification of hypoxia-responsive genes in a dopaminergic cell line by subtractive cDNA libraries and microarray analysis Parkinsonism Relat Disord. 7 273-281

7. Conrad, P.W., Millhorn, D.E., Beitner-Johnson, D. (2000) Novel regulation of p38g by dopamine D2 receptors during hypoxia Cell Signal. 12, 463-467

8.Conrad, P.W., Millhorn, D.E., and Beitner-Johnson, D. (2000) Hypoxia differentially regulates the Mitogen- and Stress-Activated Protein Kinases: Role of Ca2+/CaM in the activation of MAPK and p38 Adv Exp Med Biol. 475, 293-302

9. Millhorn, D.E., Beitner-Johnson, D., Conforti, L., Conrad, P.W., Kobayashi, S., Yuan, Y., and Rust, R. (2000) Gene regulation during hypoxia in excitable oxygen-sensing cells: Depolarization-transcription coupling Adv Exp Med Biol. 475, 131-42

10.Conrad, P.W., Freeman, T.L., Beitner-Johnson, D., and Millhorn, D.E. (1999) EPAS1 trans-activation during hypoxia requires p42/p44 MAPK J. Biol. Chem. 274, 33709-33713

11.Conrad, P.W., Rust, R.T., Han, J., Millhorn, D.E., and Beitner-Johnson, D. (1999) Selective activation of p38 and p38g by hypoxia: A role for p38 and p38g in regulation of cyclin D1 by hypoxia in PC12 cells.J. Biol. Chem. 274, 23570-23576

12.Conforti, L., Kobayashi, S., Beitner-Johnson, D., Conrad, P. W., Freeman, T. L., and Millhorn, D. E. (1999) Regulation of gene expression and secretory functions in oxygen-sensing PC12 cellsResp. Phys. 115, 249-260